Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be
effective drug delivery systems for treating various cancers. Several liposome-based …

Cancer is a life-threatening disease contributing to~ 3.4 million deaths worldwide. There are
various causes of cancer, such as smoking, being overweight or obese, intake of processed …

The application of liposomes to assist drug delivery has already had a major impact on
many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic …

Cancer nanotherapeutics are swiftly progressing and are being applied to solve several
limitations of conventional drug delivery systems such as non-specific biodistribution and …

The delivery of drugs through targeted nanocarriers that are internalized by cells provides
an alternative route to diffusion of drugs into cells. Growth factor or vitamin interactions with …

Lipid nanoparticles (LNPs) for delivery of mRNA usually contain ionizable lipid/helper
lipid/cholesterol/PEG-lipid in molar ratios of 50: 10: 38.5: 1.5, respectively. These LNPs are …

Solid lipid nanoparticles (SLN) have attracted increasing attention during recent years. This
paper presents an overview about the selection of the ingredients, different ways of SLN …

The rapid recognition of intravenously injected colloidal carriers, such as liposomes and
polymeric nanospheres from the blood by Kupffer cells, has initiated a surge of development …

This article critically examines and evaluates the likely mechanisms that contribute to
prolonged circulation times of sterically protected nanoparticles and liposomes. It is …

Opinions of the usefulness of liposomes in various biotechnological applications range from
unsubstantiated optimism to undeserved pessimism. This article reviews the background …